Ruplizumab

Tax included
Ruplizumab (BG 9588) is a humanized monoclonal anti-CD40L (TNF Receptor) IgG1κ antibody. Ruplizumab has the potential for systemic lupus erythematosus disease research.
HY-P99315

Data sheet

Size
Multiple sizes
Reactivity
TNF Receptor
Application
COVID-19-immunoregulation
CAS
220651-94-5